

A foreign shareholder discovers an undisclosed capital increase in a Turkish company. Learn how to challenge the resolution, protect pre-emption rights, investigate dilution and seek urgent court measures in 2026.
A capital increase can fundamentally change the ownership structure of a Turkish company. For a foreign shareholder, the situation becomes particularly serious when the increase was approved or implemented without the shareholder’s knowledge, resulting in dilution of voting rights, dividend participation or influence over the company. The shareholder should immediately investigate how the capital increase was authorized, whether meeting and notice requirements were followed, whether pre-emption rights were respected, whether those rights were lawfully restricted and whether the transaction was structured primarily to dilute a particular shareholder. Depending on the company’s legal form and the circumstances, corporate resolutions may potentially be challenged and urgent judicial measures may also become relevant.
Suppose a foreign investor owns 40% of a Turkish company. If other shareholders approve a substantial capital increase and the foreign investor does not participate, that percentage can fall dramatically.
The consequences may include reduced voting power, reduced dividend participation, loss of veto influence, inability to block certain corporate decisions and weakened control over future management appointments.
For that reason, the first question is not simply whether the company’s capital legally increased. The entire decision-making process should be examined.
The foreign shareholder should immediately obtain and review available corporate documents relating to the capital increase.
Important documents may include the general assembly resolution, board resolutions, meeting invitation, agenda, attendance list, amended articles of association, capital subscription documents, registry records and documents concerning restriction of shareholder rights.
The shareholder should establish a precise chronology.
The date and manner of discovery can become important because corporate litigation is subject to procedural time limits.
The shareholder should preserve emails, registry records, correspondence and other evidence showing when the transaction became known.
Waiting while negotiating informally with the controlling shareholder can create unnecessary procedural risk.
If the capital increase required a general assembly decision, examine whether the meeting was convened in accordance with applicable corporate rules and the company’s articles of association.
The foreign shareholder’s absence does not automatically make the meeting invalid. The important question is whether the legally required meeting and notification procedures were satisfied.
Review how notice was given, where it was sent and whether the company’s shareholder records contained the correct contact information.
If the controlling shareholders deliberately prevented a foreign shareholder from learning about a meeting, that fact can become highly relevant to the dispute.
A shareholder should generally be able to understand from the meeting process that a capital increase will be considered.
The actual agenda, proposed amendments and resolutions should therefore be compared carefully.
Capital increases and amendments to articles of association may be subject to statutory or contractual voting requirements depending on the company and transaction.
Calculate the votes actually present and cast rather than accepting management’s statement that the resolution was valid.
A capital increase does not necessarily mean that existing shareholders must accept dilution.
Existing shareholders may have rights allowing them to participate in newly issued capital in proportion to their existing holdings, subject to the applicable corporate-law framework and any lawful restriction.
For a diluted foreign investor, this is often one of the first issues that should be investigated.
Determine whether the shareholder received information concerning the amount of the increase, subscription terms, payment schedule and procedure for exercising relevant rights.
If no genuine opportunity was provided, the reason should be identified.
If the shareholder’s pre-emption rights were restricted or removed, examine the corporate decision and justification carefully.
Restriction of shareholder rights cannot simply be treated as an administrative convenience where the real effect is to transfer economic or voting power between shareholders.
The company may argue that new capital was urgently required to finance operations, repay debt, fund an acquisition or satisfy investment requirements.
Those explanations should be tested against the financial evidence.
Bank records, budgets, board materials, cash-flow information and the timing of the transaction may help establish whether there was a genuine financing need.
A particularly serious dispute arises where controlling shareholders allegedly use a capital increase to weaken a minority investor.
Warning signs may include an unusually large increase, very short participation periods, selective communication, restriction of pre-emption rights, issuance primarily to related parties or an absence of convincing financial need.
No single factor automatically proves abusive dilution, but the overall transaction should be examined.
Identify every person or entity receiving the newly issued shares.
If the controlling shareholder, its relatives, management or affiliated companies subscribed to most of the increase, related-party relationships may become important.
Determine whether the new capital was actually paid.
Review bank records and accounting entries where accessible. A nominal capital increase accompanied by questionable payment arrangements may raise issues different from a genuine cash injection.
Sometimes a capital increase is implemented through capitalization of shareholder receivables or another existing financial arrangement.
The underlying receivable should be examined. Determine whether it was genuine, correctly recorded and legally capable of supporting the transaction.
The foreign shareholder should obtain available financial statements, balance sheets, income statements, ledgers and other relevant financial records.
If the company had substantial cash reserves but management claims that an emergency capital increase was indispensable, the inconsistency may require explanation.
A foreign shareholder who suspects dilution frequently needs access to company records before deciding which claim to pursue.
Information and inspection mechanisms available under Turkish company law should therefore be considered alongside litigation concerning the capital increase itself.
Calculate the economic consequences.
Compare the shareholder’s ownership percentage, voting rights and economic position before and after the increase. Also determine whether the transaction affected board representation, veto thresholds or other contractual rights.
Foreign investments frequently involve a shareholders’ agreement in addition to the articles of association.
The agreement may contain reserved matters, veto rights, anti-dilution clauses, financing obligations, pre-emption rights, consent requirements and dispute-resolution provisions.
A capital increase may therefore create both corporate-law and contractual claims.
Some investment agreements specifically protect investors against dilution.
The precise wording matters. The clause may provide participation rights, adjustment mechanisms, consent requirements or another contractual remedy.
Not every contractual right appears in the registered articles of association.
The investor should compare the articles, shareholders’ agreement and actual corporate resolution to determine which rights operate at the corporate level and which may support separate contractual claims.
Potentially. Depending on the defect, the nature of the resolution and the shareholder’s procedural position, Turkish corporate law provides mechanisms for challenging unlawful general assembly resolutions.
The appropriate claim must be determined from the specific facts rather than treating every irregularity identically.
Some disputes concern a resolution that may be challenged through an annulment action, while more fundamental legal defects can raise different questions concerning invalidity.
Correct legal characterization matters because the grounds, consequences and procedural requirements may differ.
A shareholder who discovers a disputed capital increase should seek legal review immediately.
Corporate litigation can involve strict filing periods. Informal negotiations should not be allowed to consume a period necessary to protect formal rights.
Registration of the capital increase does not necessarily mean that every underlying corporate-law dispute disappears.
The shareholder should examine the legal consequences of registration together with available corporate and judicial remedies.
If implementation of the disputed transaction threatens immediate and difficult-to-reverse harm, the shareholder may need to evaluate interim judicial protection.
The appropriate request depends on the transaction, current registry position and relief sought.
If the newly issued shares are about to be transferred to third parties, urgency may increase.
The investor should determine whether additional transactions could make restoration of the corporate position substantially more complicated.
Copies of resolutions, meeting records, correspondence, financial documents and registry materials should be preserved immediately.
Foreign shareholders should not assume that access to company records will remain unchanged after litigation begins.
Communications between shareholders and management may show whether the capital increase had been discussed previously, whether information was withheld or whether dilution was an expressed objective.
Evidence should be preserved lawfully and in its original form where possible.
If directors or managers participated in an allegedly unlawful capital increase, their conduct may require separate analysis.
A corporate challenge against the resolution and potential responsibility of management are distinct issues and should not automatically be merged.
Turkish corporate law contains principles designed to prevent corporate powers from being exercised contrary to mandatory law and shareholder protections.
Where a controlling shareholder allegedly structures transactions to extract value or eliminate minority influence, the broader corporate relationship should be investigated.
An undisclosed capital increase may not be an isolated event.
Check whether the company simultaneously transferred assets, increased management compensation, entered related-party contracts, created new debt or transferred business to affiliated companies.
Financial evidence can help determine whether the capital increase actually funded the company or merely changed ownership percentages.
Where legally accessible, trace incoming capital and subsequent payments.
If the foreign investor previously issued a power of attorney in Turkey, determine whether anyone used it in connection with the disputed corporate transaction.
The scope and actual use of the authorization should be reviewed carefully.
If documents contain a signature purportedly belonging to the foreign shareholder, verify authenticity immediately.
A disputed or forged signature can transform the case from an ordinary shareholder dispute into a significantly broader legal matter.
Compare attendance records with travel information, communications and signatures.
If the investor was outside Turkey but corporate records indicate personal participation, the discrepancy requires immediate investigation.
Current and historical registry information can help reconstruct the capital increase, amendments and management changes.
The chronology should be compared with internal corporate records.
For significant investments, an independent accountant or financial expert may help reconstruct ownership percentages, payments, shareholder receivables and economic consequences.
This can be especially useful where the accounting records are disputed.
Dilution is not purely mathematical.
If new shares were issued under circumstances affecting the economic value of existing interests, valuation evidence may become relevant to damages or contractual claims.
Potentially, depending on the unlawful conduct, responsible parties, contractual arrangements and provable loss.
The shareholder should distinguish loss suffered personally from loss suffered by the company itself.
A foreign investor may potentially have corporate-law claims concerning the resolution and contractual claims under a shareholders’ agreement.
The forum and dispute-resolution clause should therefore be checked before proceedings begin.
International shareholder agreements frequently contain arbitration clauses.
Whether a particular dispute is arbitrable and whether corporate remedies must be pursued before Turkish courts requires transaction-specific analysis.
After discovering the transaction, the foreign shareholder may be asked to sign meeting minutes, waivers, updated agreements or confirmations.
No document should be signed without understanding whether it could be interpreted as approval or waiver of objections.
Management may send an updated shareholder table showing the diluted percentage as a completed fact.
Before acknowledging it, the investor should investigate the legal basis of the capital increase and available remedies.
A foreign shareholder discovering an undisclosed capital increase should immediately obtain the general assembly and board records, confirm registry changes, calculate dilution, review notification procedures, examine voting requirements, determine whether pre-emption rights were respected or restricted, identify who received the new shares, verify whether capital was actually paid, review the articles and shareholders’ agreement, preserve communications, investigate related-party transactions and assess urgent judicial measures and filing deadlines.
Potentially, provided the applicable meeting, notice, quorum and voting requirements are satisfied. Absence alone does not determine validity.
A capital increase can mathematically reduce an existing shareholder’s percentage if the shareholder does not participate, but whether the process was lawful requires examination of shareholder rights and the corporate procedure.
Pre-emption rights can be highly relevant. Their availability and any restriction should be examined under the applicable company structure and transaction.
Any restriction must be evaluated under the applicable corporate-law requirements. A restriction designed to disadvantage a particular shareholder can create significant legal issues.
Potentially. The appropriate remedy depends on the nature of the corporate resolution, procedural defects and shareholder’s legal position.
Corporate challenges can be subject to strict time limits. Immediate legal review is therefore important once the transaction is discovered.
Potentially, where the requirements for interim judicial protection are satisfied and implementation threatens difficult-to-reverse harm.
The underlying subscription and payment records should be investigated. The legal consequences depend on the company type and manner in which the capital increase was implemented.
The investor may have contractual remedies in addition to any corporate-law remedies. The dispute-resolution clause should also be reviewed.
Secure the corporate and registry records immediately and reconstruct the transaction before confronting the other shareholders. The key questions are how the increase was approved, whether the investor’s participation rights were respected, who obtained the new shares and whether the transaction had a genuine corporate financing purpose or operated as an abusive dilution mechanism.
Undisclosed capital increases can create disputes involving shareholder dilution, pre-emption rights, general assembly resolutions, corporate records, related-party transactions, shareholder agreements, interim measures and management liability. Fırat Fesih Kaya Law Office assists foreign shareholders and international investors in disputes involving Turkish companies. Lawyer Fırat Fesih Kaya provides legal assistance in investigating disputed capital increases, reviewing corporate records and shareholders’ agreements, challenging corporate resolutions, seeking urgent protective measures and pursuing contractual or compensation claims arising from shareholder dilution.
Phone: +90 312 434 22 22
Mobile: +90 532 769 22 22
Email: info@firatfesihkaya.av.tr
Address: Mevlana Boulevard No:221, Yıldırım Tower, Office No:148, 06520 Balgat, Çankaya, Ankara, Turkey